Response to immune checkpoint inhibitors in recurrent/metastatic esophageal squamous cell carcinoma may be affected by tumor site and lesion size.

Abstract

e16099Background: Heterogeneous tumor response has been reported in cancer patients receiving immune checkpoint inhibitors (ICIs). This study investigated whether or not tumor site and tumor size s...